EUVIMEDEUVIMED entdecken
Open Access

Impact of varicella vaccination on the epidemiology of herpes zoster and postherpetic neuralgia: a narrative review

Hyeon-Soo Park, Gyeong-Jo Byeon

Journal of Yeungnam Medical Science · 18.03.2026 · 43 · 22

DOI: 10.12701/jyms.2026.43.22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Yeungnam Medical Science, online erschienen am 18.03.2026. Verfasst von Hyeon-Soo Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Pusan National University Yangsan Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Varicella-zoster virus (VZV) establishes lifelong latency following primary infection and can reactivate later in life to cause herpes zoster (HZ) and its debilitating complication postherpetic neuralgia (PHN). The implementation of varicella vaccinations has profoundly altered the epidemiological landscape of VZV. This narrative review examines the current literature to evaluate the impact of these vaccination programs on the incidence of HZ and PHN. Early mathematical models based on the “exogenous boosting” hypothesis predicted a substantial surge in adult HZ due to reduced exposure to circulating wild-type virus. However, long-term epidemiological data demonstrate that the incidence of adult HZ was already increasing prior to the introduction of vaccination programs and did not accelerate post-implementation, suggesting other primary drivers, such as an aging population. This review highlights the significant decline in HZ incidence among vaccinated pediatric populations, as the attenuated vOka vaccine strain is substantially less prone to reactivation than the wild-type virus. Furthermore, HZ that does occur in vaccinated individuals tends to be milder, resulting in a reduced risk of progression to PHN. To address the persistent risk in older adults, a recombinant zoster vaccine is recommended as a highly effective secondary prevention strategy. Despite challenges, such as breakthrough infections and the need for long-term monitoring of vaccine-induced immunity, varicella vaccination remains a cornerstone of public health, offering broad protection across different ages. Further research is needed to fully understand the long-term impact of varicella vaccinations on the incidence of HZ and PHN and to identify additional risk factors for these conditions.

Schlagwörter

Stichwörter der Autor:innen

Herpes zosterImmunityNeuralgiaVaccinationVaricella

Autor:innen und Institutionen

  • Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  • Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.

Förderung

  • Pusan National University Yangsan Hospital

Zitieren

APA

Park, H. S., & Byeon, G. J. (2026). Impact of varicella vaccination on the epidemiology of herpes zoster and postherpetic neuralgia: a narrative review. Journal of Yeungnam Medical Science, 43, 22. https://doi.org/10.12701/jyms.2026.43.22

Vancouver

Park HS, Byeon GJ. Impact of varicella vaccination on the epidemiology of herpes zoster and postherpetic neuralgia: a narrative review. Journal of Yeungnam Medical Science. 2026;43:22. doi:10.12701/jyms.2026.43.22

BibTeX
@article{Park2026,
  author = {Park, Hyeon-Soo and Byeon, Gyeong-Jo},
  title = {Impact of varicella vaccination on the epidemiology of herpes zoster and postherpetic neuralgia: a narrative review},
  journal = {Journal of Yeungnam Medical Science},
  year = {2026},
  volume = {43},
  pages = {22},
  doi = {10.12701/jyms.2026.43.22}
}
Kostenlos starten →